BOK Financial’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

BOK Financial’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10	Closed	-$1.32K	–	1369
2025 Q1	$1.32K	Hold	10	–	–	﹤0.01%	1154
2024 Q4	$949	Buy	+10	New	+$822	﹤0.01%	1198

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BOK Financial's ITCI Position: Q2 2025 in Review

BOK Financial sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 10 shares — an estimated $1.32K sold.

BOK Financial first reported a position in ITCI in Q4 2024 and held it in 2 quarters. The position peaked at $1.32K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

BOK Financial reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
BOK Financial sold 10 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $1.32K.
BOK Financial first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 2 quarters.
BOK Financial's Intra-Cellular Therapies Inc. position peaked at $1.32K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on BOK Financial's 13F filing for Q2 2025, filed 12 Aug 2025.